Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-047-1 | CAS number: 26316-40-5 1 - 4.8 moles ethoxylated and 1 - 8.5 moles propoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: 1a: Guideline study (GLP)
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- Remarks:
- not mentioned
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Details on test material:
- Voranol RA 800; Molecular Mass: (average Mn = 280 g/mol)
Units of Propylene oxide, approx: 70-90%, Units of ethylene oxide: approx 10-30%
Lot #: UB06083011
Colourless viscous Fluid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals were supplied by "Charles River, Sulzfeld, Germany" and were about 10 (males) and 15 (females) weeks old and had an initial mean wights of 351 and 197 g, respectively.
Housing singly in Makrolon(R) cages Type IIIh on wood granules. All animals or the study were kept in the same room with no other animals from other studies and in an 20 Pa overpressure environment at 23°C, 55 +/-5% relative humidity and a 12 hour light/dark cycle and low-noise music.
Diet was stadard diet "Provimi Kliva 3883.0.15" pellets supplied by Provimi Kliva SA, Kaiseraugst, Switzerland ad libitum. Water was provided ad libitum.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- vehicle: demineralized water
administration volume: 10 ml/kg bw - Details on mating procedure:
- Pairing was performed overnight by placing one F0 female animal together with one F0 male rat. If sperm was detected in the vaginal smear taken on the morning following mating, this day was regarded as day 0 of gestation. Animals were paired daily during the 2-week mating and one week remating period. Females in which insemination had not been detected by the end of the 2-week mating period, were mated for another week with another male of the respective dose group which had successfully inseminated a female paired with it. F0 females found sperm-positive after the first matings but where body weight gain did not indicate pregnancy by the end of the 2-week mating period were paired again for 7 days during the remating period.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- not applicable
- Duration of treatment / exposure:
- up to 58 days.
- Frequency of treatment:
- daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Remarks:
- Basis:actual ingested
- Dose / conc.:
- 100 mg/kg bw/day
- Remarks:
- Basis:actual ingested
- Dose / conc.:
- 300 mg/kg bw/day
- Remarks:
- Basis: actual ingested
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- Basis:actual ingested
- No. of animals per sex per dose:
- 12 male and 12 female Wistar rats/dose and control group
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- ADMINISTRATION/EXPOSURE
- Treatment: The male F0 rats were each given ethylenediamine, ethoxylated and propoxylated (NLP#6) or vehicle (demineralized water) once daily for 2 weeks prior to mating, during the following mating and remating period and up to the day before necropsy (necropsy on day 40 of the study; one male which was sacrificed moribund was necropsied on day 36 of the study). NLP#6 or vehicle was administered to each of the female F0 rats once daily for 2 weeks prior to mating, during the subsequent mating and remating period, during gestation and up to the day before necropsy. Necropsy was either performed on day 4 to 7 p.p. in females which delivered, or in inseminated females which did not deliver some days after the expected day of delivery; i.e. the F0 females were treated individually differently for 42 to 58 days. - Positive control:
- No positive control
Examinations
- Parental animals: Observations and examinations:
- Clinical examination, mortality, body weight and food intake.
Urinalysis: Urine was collected for about 16 hours from 5 rats per dose and sex*. in males this was done on the first 5 males per groups on day 30. In females this was done in those five females, which had been necropsied first (day 45) mostly after pups had been killed.
Animals were fasted during collection period and water was offered for ad libitum consumption. The following parameters were determined:
- Quantitatively: Volume, density, protein per vol., creatine per vol.
- Semiquantitatively: pH, glucose, protein, blood, bilirubin, ketone bodies, urobilinogen
- microscopy of sediment
*These examinations were done as urinalysis in a subacute study (Report No. AT03512) had been erroneously incomplete. - Sperm parameters (parental animals):
- - testes
- epididymides
- histopatholocigal evaluation - Litter observations:
- - Birth and viability
- L itter siye at birth and the live index
- Sex ratio
- Clinical observation during first days of lactation
- Pup weights
- Gross pathological changes in the F1 pups. - Postmortem examinations (parental animals):
- ORGANS EXAMINED AT NECROPSY (MACROSCOPIC AND MICROSCOPIC) F0:
Organ weights: testes and epididymides (right and left organs separated)
Histopathology: testes, epididymes, and ovaries with oviducts in the control and high dose group.
Implantation sites in the uterus were counted at necropsy while number of corpora lutea in the ovaries was recorded during histopathological investigations (only control and high dose group - Postmortem examinations (offspring):
- PARAMETERS ASSESSED ON F1:
- clinical signs
- number of live and dead pups
- sex of pups
- body weights
- external macroscopical investigations (including apparent malformations) - Statistics:
- statistical significance was tested using the TASC-System; Analysis of variance (ANOVA) and in case of significant results DUNNETT´s test; 2/N CHI-Square test; in case of sigificant differences Fishers´s exact test with Bonferroni correction.
- Reproductive indices:
- - Insemination index (%): # of Sperm positive females/ # of females co-housed with a male
- Fertility index (%): # of pregnant females / # of sperm positive females
- Gestation index (%): # of females wiht live pups / # of pregnant females - Offspring viability indices:
- - Live birth index (%): # of live pups at birth / total # of pups born
- Viability index (%): # of live pups on day 4 / # of live pups born
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- no mortality observed
- Description (incidence):
- During the study no animal died in the study groups up to 1000 mg/kg.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- There were no decreases in body weights or body weight gain up to and including 1000 mg/kg in males and females during the premating period. Lactating 1000 mg/kg females exhibited a mild (6-7%) body weight depression (p<0.05), while body weight gain during lactation was unaffected.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- The semiquantitative urinalyses including the sediment showed no toxicologically relevant findings up to and including 1000 mg/kg
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Sex:
- female
- Basis for effect level:
- other: see 'Remark'
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Sex:
- female
- Basis for effect level:
- other: NOAEL as reported in the study report due to body weight depression during lactation at 1000 mg/kg. However, see comment from registrant.
- Dose descriptor:
- NOEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Sex:
- female
- Basis for effect level:
- other: Salivation at 1000 mg/kg bw/day
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Sex:
- male
- Basis for effect level:
- other: limit dose
- Dose descriptor:
- NOEL
- Effect level:
- 300 mg/kg bw/day (nominal)
- Sex:
- male
- Basis for effect level:
- other: Salivation at 1000 mg/kg bw/day
Results: P1 (second parental generation)
Target system / organ toxicity (P1)
- Critical effects observed:
- not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: reproduction/developmental toxicity
Target system / organ toxicity (F1)
- Critical effects observed:
- not specified
Results: F2 generation
Target system / organ toxicity (F2)
- Critical effects observed:
- not specified
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Survival rate of F0 animals was not reduced by treatment with ethylenediamine, ethoxylated and propoxylated at a dose level up to and including 1000 mg/kg bw/day.
Salivation directly after the administration was observed in both genders at the 1000 mg/kg dose level but an adverse effect is not concluded from this finding.
The lowest-observed-effect-level (LOEL) and the no-observed-effect level (NOEL) for salivation after administration were as follows:
Males: LOEL: 1000 mg/kg bw/day
NOEL: 300 mg/kg bw/day
Females LOEL: 1000 mg/kg bw/day
NOEL: 300 mg/kg bw/day
Body weight development was not affected to a toxicologically relevant extent in males at a dose level up to and including 1000 mg/kg. Females of the 1000 mg/kg group revealed a mild body weight gain depression during lactation.
There was no difference in food intake among groups up to and including 1000 mg/kg bw/day.
Urine parameters were not changed up to and including 1000 mg/kg bw/day.
PARAMETERS OF REPRODUCTION
Treatment related effects on reproductive parameters, i.e. insemination, fertility and gestation index, time to insemination, duration of gestation, course of birth, lactation behavior, number of corpora lutea, implantation sites, prenatal loss, litter size, sex ratio of pups, pup mortality (live birth index, viability index), pup body weight, and clinical findings of pups were not evident at a dose level up to and including 1000 mg/kg.
An indication for a teratogenic potential of ethylendiamine, ethoxylated and propoxylated, was not evident in this study at a dose level up to and including 1000 mg/kg bw/day.
PATHOLOGY
Necropsy, evaluation of male reproductive organ weight (testes, epididymides) and histopathology of reproductive organs (testes, epididymides, ovaries and oviducts) revealed no treatment related findings up to and including 1000 mg/kg.
Applicant's summary and conclusion
- Conclusions:
- The registrant considers the mild body weight depression of 6 to 7% reported in the 1000 mg/kg bw/day in female during lactation as not adverse as the body weight gain during lactation was unaffected. An adverse effect is usually considered to be equal to or greater than 10% reduction in body weight.
- Executive summary:
NLP#6 (Ethylenediamine, Ethoxylated and Propoxylated Polyol, molecular mass 280 g/mol) was administered daily via gavage in demineralized water to 12 male and 12 female Wistar rats per dose group, in doses of 0, 100, 300 or 1000 mg/kg body weight for a period of 2 weeks prior to a 2 week mating period. Males were treated then further up to necropsy (4 weeks at a minimum) and females during gestation and lactation up to their necropsy after day 4 p.p. of their pups. Investigations were performed on general tolerance of the test compound by the parental animals as well as on effects on reproduction and early postnatal development of Fl pups. The animals were regularly observed and weighed, food intake as well as urine and reproduction parameters were determined. Selected organs were weighed and organs were subjected to macroscopical and histopathological investigations. The test substance was stable in the vehicle for the duration of use. Formulations given to the rats were prepared appropriately. Survival rate of FO rats was not reduced up to and including 1000 mg/kg. At 1000 mg/kg FO rats exhibited salivation directly after the administration. An adverse effect is not concluded from this finding. In lactating females a mild body weight depression was seen at 1000 mg/kg. There was no difference in food intake among groups up to and including 1000 mg/kg. Urine parameters were not changed up to and including 1000 mg/kg. No adverse effects were seen in the weights of the testes, epididymides or ovaries. Histopathology revealed no evidence of test substance induced changes in male and female rats with respect to testes, epididymides, ovaries and oviducts at 1000 mg/kg. Up to and including 1000 mg/kg no effects on mating behavior, fertility and live birth indices, gestation parameters, number of implantation sites or prenatal loss, litter size, number of pups born, sex ratio, viability of pups and pup weights were seen. There were also no remarkable clinical or necropsy findings in pups and no adverse effect on the course of birth or lactation behavior of the dams in these groups.
Thus, the following no-observed-(adverse) effect levels were determined:
Females (body weight depression during lactation) NOAELand NOEL 300 mg/kg
Males NOEL: 1000 mg/kg NOAEL 300 mg/kg
Reproduction/Developmental Toxicity: NOAEL 1000 mg/kg
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies